ArticleJournal of clinical medicine2025

Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational Study.

Ermelinda Longo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.